Toggle light / dark theme

Photoacoustic imaging, a technique for examining living materials through the use of laser light and ultrasonic sound waves, has many potential applications in medicine because of its ability to show everything from organs to blood vessels to tumors.

Caltech’s Lihong Wang, a pioneer in the field, has developed variants of imaging that can show organs moving in real time, develop three-dimensional (3D) images of internal body parts, and even differentiate cancerous cells from healthy cells.

Wang, Bren Professor of Medical Engineering and Electrical Engineering, has now further advanced technology with what he calls Photoacoustic Topography Through an Ergodic Relay (PATER), which aims to simplify the equipment required for imaging of this type.

For now, it’s a simple network. But, it could be an important first step toward smarter and more adaptive prosthetics and brain-computer interfaces — and potentially lay the groundwork for a world where neural implants create real brain networks.

“On one side it sets the basis for a novel scenario that was never encountered during natural evolution, where biological and artificial neurons are linked together and communicate across global networks; laying the foundations for the Internet of Neuro-electronics,” Themis Prodromakis, a nanotechnology researcher and director at the University of Southampton’s Centre for Electronics Frontiers said in a press release.

“On the other hand, it brings new prospects to neuroprosthetic technologies, paving the way towards research into replacing dysfunctional parts of the brain with AI chips.”

Cardiologists at The Ohio State University Wexner Medical Center are the first in the United States to test a new type of ablation technology for patients suffering from atrial fibrillation, a common type of irregular heartbeat.

The team is participating in a global clinical trial to assess pulsed field ablation (PFA) technology to treat patients with atrial fibrillation. Developed by.

Ogba Educational Clinic


A nightmarish scene was burnt into my memory nearly two decades ago: Changainjie, Beijing’s normally chaotic “fifth avenue,” desolate without a sign of life. Schools shut, subways empty, people terrified to leave their homes. Every night the state TV channels reported new cases and new deaths. All the while, we had to face a chilling truth: the coronavirus, SARS, was so novel that no one understood how it spread or how to effectively treat it. No vaccines were in sight. In the end, it killed nearly 1,000 people.

It’s impossible not to draw parallels between SARS and the new coronavirus outbreak, COVID-19, that’s been ravaging China and spreading globally. Yet the response to the two epidemics also starkly highlights how far biotech and global collaborations have evolved in the past two decades. Advances in genetic sequencing technologies, synthetic biology, and open science are reshaping how we deal with potential global pandemics. In a way, the two epidemics hold up a mirror to science itself, reflecting both technological progress and a shift in ethos towards collaboration.

Let me be clear: any response to a new infectious disease is a murky mix of science, politics, racism, misinformation, and national egos. It’s naïve to point to better viral control and say it’s because of technology alone. Nevertheless, a comparison of the two outbreaks dramatically highlights how the scientific world has changed, for the better, in the last two decades.

They don’t waste much time getting right into it. He is 57 but has been told he is physically 47.


Dr. Aubrey de Grey of SENS Research Foundation was interviewed by the extremely popular Joe Rogan, and they discussed the damage repair approach to aging. Dr. de Grey talked about the current state of aging research, including stem cell therapies, and explained the role of SENS in developing next-generation rejuvenation biotechnology therapies. He also brought up the role of funding, a key bottleneck in research and development, and gave his prognosis on how quickly these therapies will be developed.

Wuhan Coronavirus Pandemic — new US case.

“U.S. Health and Human Services Secretary Alex Azar confirmed a new case of the coronavirus in the U.S. “Coming into this hearing, I was informed that we have a 15th confirmed case, the epidemiology of which we are still discerning,” he testified before a House panel. The new case brings the total number of cases in the U.S. to 60. The CDC has separated out 45 confirmed infections in people evacuated from a cruise ship in Japan or from Wuhan, China from its official case count.”


As of Wednesday, more than 81,000 cases of coronavirus have been reported, resulting in at least 2,764 deaths.

Need for a vaccine to stop this novel coronavirus is needed today more than ever. And it looks like we might not have to wait for long after all.

Scientists since the news of the outbreak have been working on a vaccine to combat and prevent people from the novel coronavirus and now a company called Moderna has announced that it has finally developed a coronavirus vaccine that will soon be ready for human testing.

Don’t Miss